The Impact of Exposure Group on the Progression Rate to Acquired Immunodeficiency Syndrome: A Comparison Between Intravenous Drug Users, Homosexual Men and Heterosexually Infected Subjects

References

• Carre N, Deveau C, Belanger F, Boufassa F, Persoz A, Jadand C, Rouzioux C, Delfraissy J F, Bucquet D. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 1994; 8: 797–802
   PubMedGoogle Scholar
• Mariotto A B, Mariotti S, Pezzotti P, Rezza G, Verdecchia A. Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: A comparison with male homosexuals. Am J Epidemiol 1992; 135: 428–437
   PubMed Web of Science ®Google Scholar
• Biggar R J. and the International Registry of Seroconverters. AIDS incubation in 1891 HIV seroconverters from different exposure groups. AIDS 1990; 4: 1059–1066
   PubMed Web of Science ®Google Scholar
• Galai N, Vlahov D, Margolick J B, Chen K, Graham N M, Munoz A. Changes in markers of disease progression in HIV-1 seroconverters: A comparison between cohorts of injecting drug users and homosexual men. J Acquir Immun Defic Syndr 1995; 8: 66–74
   Web of Science ®Google Scholar
• Spijkerman I J, Koot M, Prins M, Keet I P, van-den-Hoek A J, Miedema F, Coutinho R A. Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men. AIDS 1995; 9: 1085–1092
   PubMedGoogle Scholar
• Centers for Disease Control. Revision of the CDC surveillance case definition of the acquired immunodeficiency syndrome. MMWR 36 Suppl 1987; 1: 3–15
   Google Scholar
• Centers for Disease Control. Classification system for human T-iymphotropic virus type III/lymphadenopathy associated virus infections. MMWR 1986; 35: 334–339
   PubMedGoogle Scholar
• Dobloug J H, Bruun J N, Skaug K. The early introduction of HIV infection among Norwegians at highest risk. Scand J Infect Dis 1990; 22: 753–754
   PubMed Web of Science ®Google Scholar
• Directorate of Health, Norway. Notification of HTLV III/ 1LAV infections (in Norwegian). Directorate of Health. Oslo 1986
   Google Scholar
• Nilsen Ø, Hasseltvedt V, Lystad A. Number of HIV and AIDS cases in Norway (in Norwegian). Notification system for infectious diseases in Norway (MSIS-rapport), National Institute of Public Health. Oslo 1995; 23(23)
   Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Cox D R, Oaks D. Analysis of Survival Data. Chapman and Hall, New York 1984
   Google Scholar
• SPSS Base System Reference Guide, Release 6.1. SPSS Inc. 1994
   Google Scholar
• Margolick J B, Munoz A, Vlahov D, Solomon L, Astemborski J, Cohn S, Nelson K E. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA 1992; 267: 1631–1636
   PubMed Web of Science ®Google Scholar
• Mientjes G HC, van Ameijden E JC, van den Hoek A JAR, Goudsmit J, Miedema F, Coutinho R A. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment. AIDS 1993; 7: 1363–1370
   PubMedGoogle Scholar
• Eskild A, Magnus P, Sohlberg C, Kittelsen P, Olving J, Teige K, Skullerud K. Slow progression to AIDS among intravenous drug users infected with HIV in Norway. J Epidemiol Commun Health 1994; 48: 383–387
   PubMedGoogle Scholar
• Vella S, Giuliano M, Flordia M, Chiesi A, Tomino C, Seeber A, Barcherini S, Bucciardini R, Mariotti S. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients. AIDS 1995; 9: 51–56
   PubMedGoogle Scholar
• Coates R A, Farewell V T, Raboud J, Read S E, MacFadden D K, Calzavara L M, Johnson J K, Shepherd F A, Fanning M M. Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. Am J Epidemiol 1990; 132: 717–722
   PubMed Web of Science ®Google Scholar
• Brookmeyer R, Gail M H, Polk B. The prevalent cohort study and the acquired immunodeficiency syndrome. Am J Epideniol 1987; 126: 14–24
   PubMed Web of Science ®Google Scholar
• Magnus P, Samuelsen S O, Eskild A, Stigum H. HIV testing in the Norwegian population and the association with sexual behaviour (in Norwegian). J Nor Med Assoc 1994; 114: 3064–3067
   Google Scholar
• Alcabes P, Munoz A, Vlahov D, Friedland G H. Incubation period of Human Immunodeficiency Virus. Epidemiol Rev 1993; 15: 303–318
   PubMedGoogle Scholar
• Eskild A, Magnus P, Samuelsen S O, Sohlberg C, Kittelsen K. Differences in mortality rates and causes of death between HIV-positive and HIV-negative intravenous drug users. Int J Epidemiol 1993; 22: 315–20
   PubMed Web of Science ®Google Scholar
• Webster A, Lee C A, Cook-DG Grundy-JE, Emery V C, Kernoff P B, Griffiths P D. Cytomegalovirus infection and progression towards AIDS in haemophiliacs infected with human immunodeficiency virus. Lancet 1989; 2: 63–66
   PubMedGoogle Scholar
• Eskild A, Magnus P, Petersen G, Sohlberg C, Jensen F, Kittelsen P, Skaug K. Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS 1992; 6: 571–574
   PubMed Web of Science ®Google Scholar
• Phair J, Jacobson L, Detels R, Rinaldo C, Saah A, Schrager L, Munoz A. Aquired immunodeficiency syndrome occuring within 5 years of infection with human immunodeficiency virus type 1: The multicenter AIDS cohort study. J Aquir Immun Defic Syndr 1992; 5: 490–496
   PubMed Web of Science ®Google Scholar
• Flateby G, Eskild A, Brekke T, Moi H. Steady sexual relation ship with a HIV-positive partner and the progression rate to AIDS. AIDS 1996; 10: 1749–1751
   PubMedGoogle Scholar
• Rojas J M, Dopazo J, Najera I, Sanchez-Palomino S, Olivares I, Martin M J, Bernal A, Garcia-Saiz A, Najera R, Lopez-Galindez C. Molecular epidemiology of HIV in Madrid. Virus Res 1994; 31: 331–342
   PubMedGoogle Scholar
• Kuicken C L, Zwart G, Baan E, Coutinho R A, van den Hoek A R, Goudsmit J. Increasing antigenic diversity of the V3 variable domain of the Human immunodeficiency virus envelope protein in the course of the AIDS epidemic. Proc Natn Acad Sci USA 1993; 90: 9061–9065
   PubMedGoogle Scholar
• Engelstad M. Genetic diversity of env V3 loop sequences in HIV type-1 infected homosexuals, heterosexuals, intravenous drug users and hemophilia patients in Norway: high prevalence of subtype B and detection of subtype C. AIDS Res Hum Retrovir 1996; 12: 1733–1738
   PubMed Web of Science ®Google Scholar